Observation after surgery for low-risk endometrial cancer with tiny lymph node findings
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at women with low-risk endometrial cancer who had tiny amounts of cancer cells found in their sentinel lymph nodes during surgery. Doctors want to see if it's safe to avoid additional treatments like chemotherapy or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have low-risk endometrial cancer (grade 1 or 2, stage IA).
- You had a sentinel lymph node biopsy as part of your treatment.
- The biopsy found only isolated tumor cells (very tiny clusters of cancer cells).
- You are not planning any additional treatment (like chemo or radiation) after surgery.
- You have not had chemotherapy before surgery, and no other cancer in the last 5 years (except certain skin cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies tumor DNA in blood and tissue from people with aggressive endometrial cancer to better understand the disease. You donate samples during surgery and follow-up visits.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
This trial looks at better ways to predict how aggressive your endometrial cancer is before surgery, so doctors can decide if they need to check your lymph nodes. It may help tailor your treatment to avoid unnecessary procedures.
This trial tests whether a less invasive way to check if cancer has spread to lymph nodes (sentinel node biopsy) works as well as the standard method. It is for people with early-stage endometrial cancer having surgery.
This trial studies whether adding lymph node removal (lymphadenectomy) during surgery helps people with certain early-stage endometrial cancer. It focuses on patients who do not have visibly enlarged lymph nodes and who can safely have the operation.
This study looks at whether women with a very low-risk type of endometrial cancer can safely skip lymph node removal during surgery. It aims to see if the cancer stays away for at least 3 years after treatment.
Hear when a new FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.